Skip to main content

Ben Ho Park Archives

Susan G. Komen funds VICC breast cancer initiatives

Jul. 15, 2021—Susan G. Komen has announced breast cancer research grants totaling $14 million, including funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC) researchers.

Read more


AACR second session to feature Vanderbilt researchers

May. 12, 2021—The second session of the American Association for Cancer Research (AACR) Annual meeting, May 17-21, features several researchers from Vanderbilt-Ingram Cancer Center.

Read more


Park named director of Hematology and Oncology at VICC

Oct. 21, 2020—After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.

Read more


Park named interim Hematology and Oncology director

Jan. 9, 2020—Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.

Read more


Study backs genetic testing for all metastatic breast cancer patients

Sep. 5, 2019—  by Tom Wilemon Genetic testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies, according to research published Aug. 29 in JAMA Oncology. In the study, 100 patients were tested regardless of whether they met the current National...

Read more


Park named to VICC breast cancer leadership position

May. 17, 2018—  Internationally renowned breast cancer expert Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. In his academic role, he will serve as professor of Medicine. Park, who will assume his new post Sept. 1,...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more